Education
About Us
Working with TipRanks
Follow Us
Alzamend Neuro, Inc. (ALZN)
:ALZN
Total Valuation
Alzamend Neuro has a market cap or net worth of $4.56M. The enterprise value is ―.
Market Cap$4.56M
Enterprise Value―
Share Statistics
Alzamend Neuro has 6,608,591 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,608,591
Owned by Insiders3.60%
Owned by Institutions<0.01%
Financial Efficiency
Alzamend Neuro’s return on equity (ROE) is 3.83 and return on invested capital (ROIC) is 433.30%.
Return on Equity (ROE)3.83
Return on Assets (ROA)-15.75
Return on Invested Capital (ROIC)433.30%
Return on Capital Employed (ROCE)3.83
Revenue Per Employee0.00
Profits Per Employee-2.49M
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Alzamend Neuro is -2.42. Alzamend Neuro’s PEG ratio is 0.07.
PE Ratio-2.42
PS Ratio―
PB Ratio-9.26
Price to Fair Value-9.26
Price to FCF-2.86
Price to Operating Cash Flow-2.91
PEG Ratio0.07
Income Statement
In the last 12 months, Alzamend Neuro had revenue of 0.00 and earned -9.95M in profits. Earnings per share was -14.72.
Revenue0.00
Gross Profit-50.74K
Operating Income-9.94M
Pretax Income-9.95M
Net Income-9.95M
EBITDA-9.89M
Earnings Per Share (EPS)-14.72
Cash Flow
In the last 12 months, operating cash flow was -7.31M and capital expenditures 147.24K, giving a free cash flow of -7.16M billion.
Operating Cash Flow-7.31M
Free Cash Flow-7.16M
Free Cash Flow per Share-1.08
Dividends & Yields
Alzamend Neuro pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change-90.50%
50-Day Moving Average0.89
200-Day Moving Average1.69
Relative Strength Index (RSI)33.36
Average Volume (3m)182.39K
Important Dates
Alzamend Neuro upcoming earnings date is Mar 16, 2023, TBA Not Confirmed.
Last Earnings DateMar 15, 2022
Next Earnings DateMar 16, 2023
Ex-Dividend Date―
Financial Position
Alzamend Neuro as a current ratio of 0.14, with Debt / Equity ratio of 0.00%
Current Ratio0.14
Quick Ratio0.14
Debt to Market Cap0.01
Net Debt to EBITDA<0.01
Interest Coverage Ratio-983.83
Taxes
In the past 12 months, Alzamend Neuro has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Alzamend Neuro EV to EBITDA ratio is -2.42, with an EV/FCF ratio of -2.85.
EV to Sales0.00
EV to EBITDA-2.42
EV to Free Cash Flow-2.85
EV to Operating Cash Flow-2.90
Balance Sheet
Alzamend Neuro has $3.36M in cash and marketable securities with $15.52K in debt, giving a net cash position of -$3.36M billion.
Cash & Marketable Securities$3.36M
Total Debt$15.52K
Net Cash-$3.36M
Net Cash Per Share-$0.51
Tangible Book Value Per Share-$0.77
Margins
Gross margin is 66.67%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin66.67%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Alzamend Neuro is $20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$20.00
Price Target Upside2841.18% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―